Re-implantation of tumour tissue treated by cryotreatment with liquid nitrogen induces anti-tumour activity against murine osteosarcoma

Journal of Bone and Joint Surgery - Series B

Volumn 90, Issue 9, 2008, Pages 1249-1255

  Nishida, H ^a   Tsuchiya, H ^a   Tomita, K ^a  

^a KANAZAWA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 12; LIQUID NITROGEN; PICIBANIL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; AUTOGRAFT; CANCER INHIBITION; CANCER TRANSPLANTATION; CONTROLLED STUDY; CRYOTHERAPY; CYTOKINE PRODUCTION; CYTOTOXICITY; FEMALE; IMMUNE RESPONSE; LUNG METASTASIS; MOUSE; NONHUMAN; OSTEOSARCOMA; OSTEOSARCOMA CELL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SPLEEN CELL; TUMOR IMMUNITY; VISCERAL METASTASIS;

ABDOMINAL NEOPLASMS; ANIMALS; ANTINEOPLASTIC AGENTS; BONE AND BONES; BONE NEOPLASMS; CRYOPRESERVATION; FEMALE; INTERFERON TYPE II; INTERLEUKIN-12; LUNG NEOPLASMS; MICE; MICE, INBRED C3H; NITROGEN; OSTEOSARCOMA; PICIBANIL; RANDOM ALLOCATION; REPLANTATION;

EID: 53649091897     PISSN: 0301620X     EISSN: None     Source Type: Journal    
DOI: 10.1302/0301-620X.90B9.20671     Document Type: Article

References (36)

1. Bacci G, Longhi A, Versari M, et al. Prognostic factors for osteosarcoma of the extremity treated with neoadjuvant chemotherapy: 15-year experience in 789 patients treated at a single institution. Cancer 2006;106:1154-61.
2. Bielack SS, Kempf-Bielack B, Delling G, et al. Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols. J Clin Oncol 2002;20:776-90.
3. Meyers PA, Schwartz CL, Krailo M, et al. Osteosarcoma: a randomized, prospective trial of the addition of ifosfamide and/or muramyl tripeptide to cisplatin, doxorubicin, and high-dose methotrexate. J Clin Oncol 2005;23:2004-11.
4. Provisor AJ, Ettinger LJ, Nachman JB, et al. Treatment of non-metastatic osteosarcoma of the extremity with preoperative and postoperative chemotherapy: a report from the Children's Cancer Group. J Clin Oncol 1997;15:76-84.
5. Tsuchiya H, Yasutake H, Yokogawa A, et al. Effect of chemotherapy combined with caffeine for osteosarcoma. J Cancer Res Clin Oncol 1992;118:567-9.
6. Tsuchiya H, Tomita K, Mori Y, Asada N, Yamamoto N. Marginal excision for osteosarcoma with caffeine assisted chemotherapy. Clin Orthop 1999;358:27-35.
7. Tsuchiya H, Tomita K, Mori Y, et al. Caffeine-assisted chemotherapy and minimized tumor excision for non metastatic osteosarcoma. Anticancer Res 1998;18:657-66.
8. Tsuchiya H, Kanazawa Y, Abdel-Wanis ME, et al. Effect of timing of pulmonary metastases identification on prognosis of patients with osteosarcoma: the Japanese Musculoskeletal Oncology Group study. J Clin Oncol 2002;20:3470-7.
9. Huang A, McCall JM, Weston MD, et al. Phase I study of percutaneous cryotherapy for colorectal liver metastasis. Br J Surg 2002;89:303-10.
10. Chin JL, Lim D, Abdelhady M. Review of primary and salvage cryoablation for prostate cancer. Cancer Control 2007;14:231-7.
11. Atwell TD, Farrell MA, Callstrom MR, et al. Percutaneous cryoablation of large renal masses: technical feasibility and short-term outcome. AJR Am J Roentgenol 2007;188:1195-200.
12. Sabel MS, Kaufman CS, Whitworth P, et al. Cryoablation of early-stage breast cancer: work-in-progress report of a multi-institutional trial. Ann Surg Oncol 2004;11:542-9.
13. Marcove RC, Weis LD, Vaghaiwalla MR, Pearson R, Huvos AG. Cryosurgery in the treatment of giant cell tumors of bone: a report of 52 consecutive cases. Cancer 1978;41:957-69.
14. Marcove RC, Sheth DS, Takemoto S, Healey JH. The treatment of aneurysmal bone cyst. Clin Orthop 1995;311:157-63.
15. Tsuchiya H, Wan SL, Sakayama K, et al. Reconstruction using an autograft containing tumour treated by liquid nitrogen. J Bone Joint Surg [Br] 2005;87-B:218-25.
16. Yamamoto N, Tsuchiya H, Tomita K. Effects of liquid nitrogen treatment on the proliferation of osteosarcoma and the biomechanical properties of normal bone. J Orthop Sci 2003;8:374-80.
17. Urano M, Tanaka C, Sugiyama Y, Miya K, Saji S. Antitumour effects of residual tumor after cryoablation: the combined effect of residual tumor and a protein-bound polysaccharide on multiple liver metastases in a murine model. Cryobiology 2003;46:238-45.
18. Kosaka K. Fundamental guidelines for proper conduct of animal experiments and related activities in academic research institutions under the jurisdiction of the Ministry of Education, Culture, Sports, Science and Technology. http://www.lifescience.mext.go.jp/policies/pdf/an_material011.pdf (date last accessed 29 October 2007).
19. Asai T, Ueda T, Itoh K, et al. Establishment and characterization of a murine osteosarcoma cell line (LM8) with high metastatic potential to the lung. Int J Cancer 1998;76:418-22.
20. Okamoto M, Furuichi S, Nishioka Y, et al. Expression of toll-like receptor 4 on dendritic cells is significant for anticancer effect of dendritic cell-based immunotherapy in combination with an active component of OK-432, a streptococcal preparation. Cancer Res 2004;64:5461-70.
21. Wang X, Fujimoto T, Zhang B, Mai M. Streptococcal preparation OK-432 enhances the anti tumor activity of CPT-11 by increasing Th1-cytokine production in mice. Anticancer Res 2001;21:2505-10.
22. Johnson JP. Immunologic aspects of cryosurgery: potential modulation of immune recognition and effector cell maturation. Clin Dermatol 1990;8:39-47.
23. Hoffmann NE, Coad JE, Huot CS, Swanlund DJ, Bischof JC. Investigation of the mechanism and the effect of cryoimmunology in the Copenhagen rat. Cryobiology 2001;41:59-68.
24. Alblin RJ, Soanes WA, Gonder MJ. Prospects for cryo-immunotherapy in cases of metastasizing carcinoma of the prostate. Cryobiology 1971;8:271-9.
25. Miya K, Saji S, Morita T, et al. Immunological response of regional lymph nodes aftert umor cryosurgery: experimental study in rats. Cryobiology 1986;23:290-5.
26. Sabel MS, Nehs MA, Su G, et al. Immunologic response to cryoablation of breast cancer. Breast Cancer Res Treat 2005;90:97-104.
27. Lubaroff DM, Reynolds CW, Canfield L, McElligott D, Feldbush T. Immunologic aspects of the prostate. Prostate 1981;2:233-48.
28. Joosten JJ, Muijen GN, Wobbes T, Ruers TJ. In vivo destruction of tumor tissue by cryoablation can induce inhibition of secondary tumor growth: an experimental study. Cryobiology 2001;42:49-58.
29. Udagawa M, Kudo-Saito C, Hasegawa G, et al. Enhancement of immunologic tumor regression by intra tumoral administration of dendritic cells in combination with cryoablative tumor pretreatment and bacillus Calmette-Guerin cell wall skeleton stimulation. Clin Cancer Res 2006;12:7465-75.
30. Müller LC, Micksche M, Yamagata S, Kershbaumer F. Thereapeutic effect of cryosurgery of murine osteosarcoma: influence on disease outcome and immune function. Cryobiology 1985;22:77-85.
31. Machlenkin A, Goldberger O, Tirosh B, et al. Combined dendritic cell cryosurgery of tumor induces systemic antimetastatic immunity. Clin Cancer Res 2005;11:4955-61.
32. den Brok MH, Sutmuller RP, Nierkens S, et al. Efficient loading on dendritic cells following cryo and radiofrequency ablation in combination with immune modulation induces anti-tumor immunity. Br J Cancer 2006;95:896-905.
33. Osada S, Imai H, Tomita H, et al. Serum cytokine levels in response to hepatic cryoablation. J Surg Oncol 2007;95:491-8.
34. Lee PP, Yee C, Savage PA, et al. Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients. Nat Med 1999;5:677-85.
35. Townsend SE, Allison JP. Tumor rejection after direct costimulation of CD8+ T cells by B7-transfected melanoma cells. Science 1993;259:368-70.
36. Tada T, Ohzeki S, Utsumi K, et al. Transforming growth factor-beta-induced inhibition of T cell function: susceptibility difference in T cells of various phenotypes and functions and its relevance to immunosuppression in the tumor-bearing state. J Immunol 1991;146:1077-82.